Man Group’s OrthoPediatrics KIDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-8,008
Closed -$260K 2199
2023
Q4
$260K Buy
+8,008
New +$232K ﹤0.01% 1856
2022
Q2
Sell
-16,261
Closed -$878K 2243
2022
Q1
$878K Sell
16,261
-6,257
-28% -$320K ﹤0.01% 1419
2021
Q4
$1.35M Buy
22,518
+2,341
+12% +$146K ﹤0.01% 1263
2021
Q3
$1.32M Sell
20,177
-8,814
-30% -$572K ﹤0.01% 1282
2021
Q2
$1.83M Sell
28,991
-6,295
-18% -$362K 0.01% 1245
2021
Q1
$1.72M Buy
+35,286
New +$1.69M 0.01% 1154

Other funds holding KIDS

Man Group's KIDS Position: Q1 2024 in Review

Man Group sold out of OrthoPediatrics (KIDS) in Q1 2024, closing a stake of 8,008 shares — an estimated $260K sold.

Man Group first reported a position in KIDS in Q1 2021 and held it in 6 quarters. The position peaked at $1.83M in Q2 2021. 121 funds tracked by Wall St. Rank hold KIDS as of Q1 2024.

  • Man Group reported no remaining OrthoPediatrics position as of Q1 2024 after selling out during the quarter.
  • Man Group sold 8,008 OrthoPediatrics shares in Q1 2024, an estimated $260K.
  • Man Group first reported a position in OrthoPediatrics in Q1 2021 and held it in 6 quarters.
  • Man Group's OrthoPediatrics position peaked at $1.83M in Q2 2021.
  • 121 funds tracked by Wall St. Rank held OrthoPediatrics as of Q1 2024.

Based on Man Group's 13F filing for Q1 2024, filed 15 May 2024.